Free Trial

Cross Country Healthcare, Inc. (NASDAQ:CCRN) Shares Acquired by Royce & Associates LP

Cross Country Healthcare logo with Business Services background
Remove Ads

Royce & Associates LP lifted its position in shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) by 3.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,170,945 shares of the business services provider's stock after purchasing an additional 38,379 shares during the period. Royce & Associates LP owned about 3.57% of Cross Country Healthcare worth $21,264,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in CCRN. Truvestments Capital LLC acquired a new position in Cross Country Healthcare during the third quarter worth approximately $39,000. Plato Investment Management Ltd acquired a new position in shares of Cross Country Healthcare in the 4th quarter valued at $46,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Cross Country Healthcare in the 3rd quarter valued at $49,000. Point72 DIFC Ltd acquired a new stake in Cross Country Healthcare during the 3rd quarter worth $52,000. Finally, Gladius Capital Management LP boosted its stake in Cross Country Healthcare by 83.4% during the 3rd quarter. Gladius Capital Management LP now owns 3,985 shares of the business services provider's stock worth $54,000 after purchasing an additional 1,812 shares during the period. 96.03% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. Benchmark cut shares of Cross Country Healthcare from a "strong-buy" rating to a "hold" rating in a report on Wednesday, December 4th. William Blair cut Cross Country Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, December 4th. Truist Financial boosted their target price on Cross Country Healthcare from $15.00 to $18.61 and gave the company a "hold" rating in a report on Thursday, December 5th. StockNews.com began coverage on Cross Country Healthcare in a report on Thursday. They set a "hold" rating for the company. Finally, Barrington Research reissued a "market perform" rating and issued a $18.61 price objective on shares of Cross Country Healthcare in a research note on Friday, March 14th. Six research analysts have rated the stock with a hold rating, According to data from MarketBeat.com, Cross Country Healthcare currently has an average rating of "Hold" and a consensus target price of $18.41.

Remove Ads

Read Our Latest Stock Analysis on CCRN

Cross Country Healthcare Trading Down 0.9 %

Shares of CCRN traded down $0.14 during mid-day trading on Thursday, hitting $14.80. The company's stock had a trading volume of 208,667 shares, compared to its average volume of 581,374. Cross Country Healthcare, Inc. has a 1-year low of $9.58 and a 1-year high of $19.18. The firm has a market capitalization of $485.63 million, a P/E ratio of -295.94, a P/E/G ratio of 3.32 and a beta of 0.44. The firm has a 50-day simple moving average of $17.49 and a 200 day simple moving average of $15.18.

About Cross Country Healthcare

(Free Report)

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

Further Reading

Institutional Ownership by Quarter for Cross Country Healthcare (NASDAQ:CCRN)

Should You Invest $1,000 in Cross Country Healthcare Right Now?

Before you consider Cross Country Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.

While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads